How to Get Ozempic for Free: Real Programs and Application Paths

Trust signals

> Reviewed by FormBlends Medical Team · Last updated May 2026 · 12 sources cited · Author: FormBlends Editorial

Key Takeaways

• Four real paths to free or near-free Ozempic: Novo Cares, Medicaid, FQHCs with 340B pricing, hospital charity care
• Novo Cares serves uninsured low-income patients (typically under 400% federal poverty level)
• Medicaid coverage varies by state; type 2 diabetes coverage is common, weight-loss coverage is rare
• FQHCs offer sliding-scale fees and 340B-priced medications including Ozempic to qualifying patients
• Manufacturer savings cards can reduce insured patients' copays to $25/month effectively delivering near-free medication

Direct answer

You can get Ozempic at no or minimal cost through four programs in 2026. Novo Cares patient assistance provides medication at reduced or no cost to qualifying uninsured patients with household income under 400% of federal poverty level. Medicaid covers Ozempic for type 2 diabetes in most states (coverage details vary by state). Federally Qualified Health Centers (FQHCs) offer 340B-priced medications and sliding-scale fees for eligible patients. Hospital charity care programs assist patients with documented financial need. Each has eligibility requirements but can deliver Ozempic at no cost when criteria are met.

Table of contents

1. The four free or near-free paths
2. Path 1: Novo Cares patient assistance
3. How to apply to Novo Cares
4. Path 2: Medicaid coverage
5. State-by-state Medicaid variation
6. Path 3: Federally Qualified Health Centers (FQHCs)
7. What 340B drug pricing means
8. Path 4: Hospital charity care
9. Manufacturer savings cards (for insured patients)
10. What to avoid: "free Ozempic" scams
11. Contrary view: should these programs exist at all
12. Decision framework
13. FAQ
14. Sources

The four free or near-free paths

Path	Cost	Eligibility	Timeline
Novo Cares	$0 or reduced	Uninsured, under 400% FPL income	1-3 weeks to approval
Medicaid (varies by state)	$0-$4 copay typically	Medicaid eligibility + T2D diagnosis	1-2 weeks for prior auth
FQHC + 340B	Sliding-scale fees; often very low or $0	FQHC patient, qualifying income	Initial visit + follow-up
Hospital charity care	$0 or reduced	Documented financial need; varies by hospital	Application takes weeks

Path 1: Novo Cares patient assistance

Novo Cares is Novo Nordisk's patient assistance program. It provides medications including Ozempic, Wegovy, Saxenda, and others at reduced or no cost to qualifying patients.

Eligibility:

• U.S. resident
• Uninsured (no commercial insurance, Medicare Part D, or Medicaid)
• Household income below specific thresholds (typically 400% of federal poverty level, adjusted annually)
• Prescriber attestation on the application

Patients with insurance that does not cover Ozempic may also qualify in some scenarios; verify with Novo Cares directly.

The program provides medication directly to the patient or prescriber's office. There is no copay for approved patients; the medication is provided at no cost.

How to apply to Novo Cares

1. Obtain a valid Ozempic prescription from a licensed clinician with documented type 2 diabetes diagnosis
2. Download the Novo Cares application form (from the Novo Cares website or through your prescriber)
3. Complete patient sections with personal information, household details, and income disclosure
4. Have prescriber complete prescriber sections and sign
5. Submit proof of income (tax return, W-2, pay stubs, or other documentation)
6. Submit proof of uninsured status (Medicaid denial letter, employer attestation, or similar)
7. Submit completed application by fax, mail, or online portal
8. Foundation reviews and approves or denies within 1-3 weeks
9. If approved, medication ships to prescriber's office or patient address
10. Renewal required annually with updated income documentation

For 2026, approximate income thresholds (400% of federal poverty level):

• Single household: under $60,240
• Two-person household: under $81,760
• Three-person household: under $103,280
• Family of four: under $124,800

These thresholds are approximate. Verify current eligibility through the Novo Cares program directly. Income limits adjust annually.

Path 2: Medicaid coverage

Medicaid is jointly funded by federal and state governments but administered at the state level. Coverage of Ozempic varies by state Medicaid program.

Typical Medicaid coverage patterns:

• Type 2 diabetes: Most state Medicaid programs cover Ozempic with prior authorization
• Step therapy: Many require metformin trial or other diabetes medication trial before Ozempic
• Off-label weight loss: Rarely covered by Medicaid
• Wegovy for obesity: Coverage varies dramatically; some states cover, others exclude all weight-loss drugs

Medicaid copays for covered medications are typically very low: $0 to $4 per fill is common, with some states having no copay at all.

To pursue Medicaid coverage for Ozempic:

1. Verify Medicaid eligibility in your state (income, residency, household size)
2. Enroll in Medicaid if eligible
3. See a provider who accepts Medicaid for evaluation
4. Get prescribed Ozempic with documented T2D
5. Provider submits prior authorization to Medicaid
6. Pickup at participating pharmacy with minimal copay

State-by-state Medicaid variation

Medicaid coverage of Ozempic varies in three main ways:

Inclusion in formulary. Most states include Ozempic in their preferred drug list for type 2 diabetes. A few states require step therapy or non-preferred status. Verify with your state Medicaid pharmacy benefit.

Step therapy requirements. Some states require trials of metformin, sulfonylurea, DPP-4 inhibitor, or other diabetes medications before approving Ozempic. Documentation requirements vary.

Weight-loss coverage. Most state Medicaid programs do not cover Ozempic for off-label weight loss. Some states (notably California Medi-Cal) cover Wegovy for documented obesity with criteria. Others exclude all anti-obesity medications.

Medicaid expansion under the Affordable Care Act increased Medicaid eligibility in adopting states. As of 2026, 40 states plus DC have adopted Medicaid expansion. Non-expansion states have stricter eligibility based on traditional Medicaid criteria.

Path 3: Federally Qualified Health Centers (FQHCs)

FQHCs are community-based health centers that receive federal funding to serve underserved populations. They are required to:

• Provide care regardless of patient ability to pay
• Offer sliding-scale fees based on income
• Serve populations that meet federal definitions of "medically underserved"
• Provide comprehensive primary care services

FQHCs participate in the federal 340B Drug Pricing Program, which provides medications at substantially reduced prices.

To use an FQHC for Ozempic access:

1. Find an FQHC in your area (search hrsa.gov/find-help)
2. Schedule a primary care appointment
3. Get evaluated for type 2 diabetes management
4. If Ozempic is appropriate, get prescribed with sliding-scale fee for the office visit
5. Fill prescription at the FQHC pharmacy (if available) or partnered pharmacy at 340B pricing

FQHC pricing for Ozempic varies but is typically substantially below cash-pay retail. Some FQHCs provide medication at no cost for patients meeting specific income criteria; others charge sliding-scale fees that may be $5-$50/month for very low-income patients.

What 340B drug pricing means

The 340B Drug Pricing Program is a federal program created in 1992 that requires drug manufacturers to provide outpatient drugs at significantly reduced prices to eligible healthcare organizations including FQHCs, Ryan White HIV/AIDS Program grantees, and certain hospitals.

Key features:

• 340B prices are typically 30-60% below average wholesale price
• Only eligible "covered entities" can purchase at 340B prices
• The savings can be passed to qualifying patients or used to subsidize the covered entity's services

For patients, the practical effect is that 340B-eligible providers can offer medications at substantially reduced cost. Ozempic through a 340B-eligible FQHC can sometimes be available for under $50/month for patients meeting sliding-scale criteria.

The 340B program is administered by the Health Resources and Services Administration (HRSA). It has been subject to ongoing policy debates about scope, manufacturer compliance, and patient benefit; the practical effect for patients in 2026 is that 340B pricing remains available through participating providers.

Path 4: Hospital charity care

Many hospital systems offer charity care programs for patients with documented financial need who do not qualify for Medicaid or manufacturer programs. Coverage varies significantly by hospital:

• Non-profit hospitals (especially Catholic-affiliated systems) typically have more developed charity care programs
• For-profit hospital chains have less generous charity care historically
• Public hospital systems (county and state) generally serve uninsured patients with sliding-scale care
• Some hospitals offer prescription assistance programs that extend charity care to medications including GLP-1 agonists

To pursue hospital charity care:

1. Ask the hospital's financial counseling department about charity care
2. Submit documentation of income, expenses, and family situation
3. Apply specifically for prescription medication assistance if available
4. Some programs cover only services received at the hospital; others extend to outpatient prescriptions

Hospital charity care decisions are often discretionary. Persistent advocacy and documented need improve outcomes. Patient advocates and social workers at the hospital can help navigate applications.

Manufacturer savings cards (for insured patients)

Novo Nordisk's Ozempic Savings Card is not a "free Ozempic" program for the uninsured. It reduces copays for commercial insurance patients. Card terms:

• Requires commercial insurance coverage (not Medicare, Medicaid, or VA)
• Reduces copay to $25/month for many eligible patients
• Lifetime maximum benefits (typically $300/fill, $3,600/year)
• Patient enrolls through Novo Nordisk's website or pharmacy

For commercially-insured patients with coverage that has high copays, the savings card can effectively deliver near-free Ozempic at the point of pickup. It does not work for uninsured patients regardless of need.

What to avoid: "free Ozempic" scams

The popularity of Ozempic has spawned numerous scam websites and ads promising "free Ozempic." Red flags:

• Promises of free Ozempic with no eligibility requirements
• Required upfront payment for "shipping" or "processing"
• Overseas shipping or international sources
• Generic websites without verifiable business information
• Requests for credit card information before any approval process

Legitimate free Ozempic programs (Novo Cares, Medicaid, FQHCs, hospital charity) all have eligibility requirements, application processes, and clear documentation. Anything bypassing these is not legitimate.

The FDA has documented counterfeit Ozempic in gray-market and scam-website supply chains. Counterfeit products have caused hospitalizations. The risk is not theoretical.

Contrary view: should these programs exist at all

Arguments for patient assistance programs:

• They provide essential medication to patients who would otherwise go without
• They reflect manufacturer commitment to patient access beyond commercial pricing
• They demonstrate that affordable pricing is possible when manufacturers choose to offer it

Arguments that they reflect a broken system:

• Patient assistance programs exist because list prices are unaffordable; lower list prices would reduce need for assistance
• Programs require burdensome paperwork and renewal requirements that exclude eligible patients
• Income thresholds create a coverage gap (uninsured patients above 400% FPL fall outside both Medicaid and patient assistance)
• Manufacturer-led programs serve marketing functions as well as access functions

The Inflation Reduction Act's drug price negotiation provisions and broader healthcare reform discussions in 2025-2026 reflect ongoing tension between manufacturer-led access programs and structural pricing reform. The current patient assistance landscape is the workable system available now, even if it falls short of ideal.

The pragmatic position: use available programs while they exist. Advocate for broader access. Recognize that "free Ozempic" through these programs is meaningfully different from the broader question of affordable prescription drug pricing.

Decision framework

You have type 2 diabetes, uninsured, under 400% FPL: Apply for Novo Cares patient assistance.

You have T2D, qualify for Medicaid in your state: Enroll in Medicaid and pursue Ozempic coverage with prior authorization.

You have T2D, low income but not Medicaid-eligible: Visit an FQHC for evaluation and 340B-priced medication.

You have T2D, documented financial need, prefer hospital-based care: Apply for hospital charity care prescription assistance.

You have commercial insurance with high copays: Apply for Novo Nordisk's Ozempic Savings Card to reduce copays.

You see "free Ozempic" ads online without eligibility requirements: Do not engage. Use only the legitimate programs above.

You don't qualify for any of these but cannot afford retail cash-pay: Compounded semaglutide ($200-$500/month) is a lower-cost alternative through state-licensed 503A pharmacies.

FAQ

How can I get Ozempic for free? Four real paths: Novo Cares (uninsured low-income), Medicaid (where covered), FQHCs with 340B pricing, hospital charity care.

What is Novo Cares? Novo Nordisk's patient assistance program providing medications at no or reduced cost to qualifying uninsured low-income patients.

Does Medicaid cover Ozempic? Yes in most states for type 2 diabetes with prior authorization. Coverage varies by state.

How do I qualify for Novo Cares? Uninsured U.S. resident with household income below 400% of federal poverty level, prescriber attestation required.

Can I get Ozempic free if I have insurance? Sometimes through the manufacturer savings card, which reduces copays to $25/month for commercially-insured patients.

What are FQHCs and how do they help? Community health centers with sliding-scale fees and 340B drug pricing. Find at hrsa.gov.

Does hospital charity care cover Ozempic? Some hospitals offer prescription assistance through charity care programs for patients with documented financial need.

What if I do not qualify for any free program? Compounded semaglutide ($200-$500/month), state pharmacy assistance programs, ACA marketplace insurance, or Medicaid expansion eligibility.

Sources

1. FDA. Ozempic Prescribing Information. Current revision 2025.
2. Novo Nordisk. Novo Cares Patient Assistance Program: Eligibility and Application Process. 2025.
3. Novo Nordisk. Ozempic Savings Card: Terms and Eligibility. 2025.
4. U.S. Department of Health and Human Services. Federal Poverty Level Guidelines. 2026.
5. Centers for Medicare and Medicaid Services. Medicaid Coverage of Outpatient Prescription Drugs. State-by-State Survey 2025.
6. Health Resources and Services Administration. Federally Qualified Health Centers Locator and Information. Accessed May 2026.
7. Health Resources and Services Administration. 340B Drug Pricing Program: Patient Eligibility and Covered Entity Requirements. 2025.
8. National Association of Community Health Centers. FQHC Sliding Fee Discount Schedule Guidance. 2024.
9. American Hospital Association. Hospital Charity Care Policies: Survey and Standards. 2024.
10. Centers for Medicare and Medicaid Services. Inflation Reduction Act Drug Price Negotiation. 2025-2026.
11. FDA. Counterfeit Ozempic Safety Communications. 2023 and 2024.
12. National Conference of State Legislatures. Medicaid Coverage of Anti-Obesity Drugs: State Survey. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform connecting patients with independent licensed clinicians and U.S.-based pharmacies. We do not administer patient assistance programs or determine eligibility for Medicaid, Novo Cares, FQHCs, or hospital charity care. Eligibility decisions are made by the relevant programs.

Compounded Medication Notice. Compounded semaglutide is prepared by a state-licensed 503A pharmacy in response to an individual prescription. It is not FDA-approved and is not interchangeable with brand Ozempic. Compounded products are typically less expensive than brand Ozempic but are not free; the savings paths described in this article apply primarily to brand Ozempic.

Results Disclaimer. Eligibility criteria, income thresholds, and program details change annually. Verify current eligibility with the specific program before applying. Approval is not guaranteed; programs make individual determinations based on documentation.

Trademark Notice. Ozempic, Wegovy, Novo Cares, and Saxenda are registered trademarks of Novo Nordisk A/S. Mounjaro, Zepbound, LillyDirect, and Lilly Cares are trademarks of Eli Lilly and Company. Medicaid is a federal-state program administered by CMS. The 340B Drug Pricing Program is administered by HRSA. FormBlends is not affiliated with these manufacturers or government programs.